UnitedHealth Group Stock Target Price and Analyst Consensus

UNH Stock  USD 491.23  9.90  1.98%   
The prevalent analyst and expert consensus on UnitedHealth Group is Strong Buy with 17 strong buy estimates. The prevailing projected target price is 558.19 with 27 professional opinions. Some of the most common ways UnitedHealth Group analysts use to provide public buy-or-sell recommendation are financial statements evaluation and conference calls analysis. They also talk to UnitedHealth Group executives, vendors, and customers. UnitedHealth Group buy-or-sell recommendation and consensus module provides average expert sentiment on the projected UnitedHealth Group target price to derive its highest and lowest estimates based on target price volatility of 0.0. Check out Macroaxis Advice on UnitedHealth Group to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
507.95
Highest Forecast
619.59
Target Price
558.19
As of now, UnitedHealth Group's Gross Profit is increasing as compared to previous years. The UnitedHealth Group's current Gross Profit Margin is estimated to increase to 0.29, while Pretax Profit Margin is projected to decrease to 0.06. As of now, UnitedHealth Group's Property Plant And Equipment Net is increasing as compared to previous years. The UnitedHealth Group's current Net Debt is estimated to increase to about 44.1 B, while Non Currrent Assets Other are projected to decrease to under 10.9 B.
  
It's important to approach UnitedHealth Group's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize UnitedHealth Group price targets

UnitedHealth Group's stock target price is an estimate of its future price, usually made by analysts. Using UnitedHealth Group's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at UnitedHealth Group's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if UnitedHealth Group's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional UnitedHealth Group Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of UnitedHealth Group is a key component of UnitedHealth Group valuation and have some predictive power on the future returns of a UnitedHealth Group.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of UnitedHealth Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
489.51491.17492.83
Details
Intrinsic
Valuation
LowRealHigh
442.11522.44524.10
Details
Earnings
Estimates (0)
LowProjected EPSHigh
5.866.757.17
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as UnitedHealth Group. Your research has to be compared to or analyzed against UnitedHealth Group's peers to derive any actionable benefits. When done correctly, UnitedHealth Group's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in UnitedHealth Group.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Blockchain Idea
Blockchain
Invested a lot of shares
Chemicals Idea
Chemicals
Invested over 40 shares
Investor Favorites Idea
Investor Favorites
Invested over 50 shares
ESG Investing Idea
ESG Investing
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 70 shares
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:
Check out Macroaxis Advice on UnitedHealth Group to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for UnitedHealth Stock analysis

When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
The data published in UnitedHealth Group's official financial statements usually reflect UnitedHealth Group's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of UnitedHealth Group. For example, before you start analyzing numbers published by UnitedHealth accountants, it's critical to develop an understanding of what UnitedHealth Group's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of UnitedHealth Group's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, UnitedHealth Group's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in UnitedHealth Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of UnitedHealth Group Incorporated. Please utilize our Beneish M Score to check the likelihood of UnitedHealth Group's management manipulating its earnings.